Objective: This article reviews the basic principles, equipment, current therapeutic status and future trends of microwave ablation (MWA) in the treatment of hepatocellular carcinoma (HCC). Methods: All articles published in English on MWA or MWA as a treatment for HCC were identified with a PubMed search from the 1990s through June 2007. Papers were reviewed on the technical advances of MWA equipment and the clinical applications of MWA including indications, techniques, therapeutic outcomes, complications and combination therapies. Results: MWA has several advantages, including high thermal efficiency, higher capability of coagulating blood vessels, faster ablation time, and an improved convention profile. MWA can induce large ablation volumes and yield good local tumor control, especially for small HCC. Larger HCC can also be completely ablated by using more effective antenna or simultaneous application of multiple antennae. Long-term survival comparable to that of surgery was obtained for tumors measuring 4 cm or less. Associated complications appear to be low. Conclusions: MWA is a promising minimally invasive technique for the treatment of HCC. Future advances are warranted to improve the therapeutic efficacy.

1.
Colombo M: Hepatocellular carcinoma. J Hepatol 1992;15:225–236.
2.
Esquivel CO, Keeffe EB, Garcia G, Imperial JC, Millan M, Monge H, So SK: Hepatic neoplasms: advances in treatment. J Gastroenterol Hepatol 1999;14(suppl):37–41.
3.
Liver Cancer Study Group of Japan: Primary liver cancers in Japan. Cancer 1980;45:2263–2269.
4.
Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J: Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg 1995;221:291–298.
5.
Kuriyama H, Okada S, Okusaka T, Ueno H, Ikeda M: Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection. J Gastroenterol Hepatol 2002;17:1205–1210.
6.
Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, Uchiyama S, Inoue K: Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817–825.
7.
Matsukawa T, Yamashita Y, Arakawa A, Nishiharu T, Urata J, Murakami R, Takahashi M, Yoshimatsu S: Percutaneous microwave coagulation therapy in liver tumors: a 3-year experience. Acta Radiol 1997;38:410–415.
8.
Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, Okamura A, Inoue K: Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999;85:1694–1702.
9.
Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J: Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002;223:331–337.
10.
Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, Wang XD, Xin H, Li S: Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. AJR 1998;171:449–454.
11.
Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ, Huang JF: Hepatocellular carcinoma: sonography-guided percutaneous microwave coagulation therapy. Radiology 2001;221:167–172.
12.
Dong BW, Liang P, Yu XL, Su L, Yu DJ, Cheng ZG, Zhang J: Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR 2003;180:1547–1555.
13.
Liang P, Dong BW, Yu XL, Yu DJ, Wang Y, Feng L, Xiao QJ: Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299–307.
14.
Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL: Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 2005,40:1054–1060.
15.
Goldberg SN, Charboneau JW, Dodd GD, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan JP, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ: Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003;228:335–345.
16.
English NJ, MacElroy JM: Molecular dynamics simulations of microwave heating of water. J Chem Phys 2003;118:1589–1592.
17.
Diederich CJ: Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation. Int J Hyperthemia 2005;21:745–753.
18.
Metaxas AC, Meredith RJ: Industrial Microwave Heating. London, Peter Peregrinus Ltd, 1983, pp 281–282.
19.
Skinner MG, Iizuka MN, Kolios MC, Sherar MD: A theoretical comparison of energy sources – microwave, ultrasound and laser – for interstitial thermal therapy. Phys Med Biol 1998;43:3535–3547.
20.
Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT Jr: Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005;236:132–139.
21.
Wright AS, Lee FT Jr, Mahvi DM: Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003;10:275–283.
22.
Bertram JM, Yang D, Converse MC, Webster JG, Mahvi D: A review of coaxial-based interstitial antennas for hepatic microwave ablation. Crit Rev Biomed Eng 2006;34:187–213.
23.
Goldberg SN, Gazelle GS, Mueller PR: Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR 2000;174:323–330.
24.
Tabuse K: A new operative procedure of hepatic surgery using a microwave tissue coagulator. Arch Jpn Chir 1979;48:160–172.
25.
Saitsu H, Yoshida M, Taniwaki S, Sato H, Okami N, Matsumoto A, Shigetomi K, Sugiyama T, Okuda Y, Nakayama K: Laparoscopic coagulo-necrotic therapy using microtase for small hepatocellular carcinoma. Jpn J Gastroenterol 1991;88:2727.
26.
Kuang M, Lu MD, Xie XY, Xu HX, Mo LQ, Liu GJ, Xu ZF, Zheng YL, Liang JY: Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna: experimental and clinical studies. Radiology 2007;242:914–924.
27.
Schaller G, Erb J, Engelbrecht R: Field simulation of dipole antennas for interstitial microwave hyperthermia. IEEE Trans Microwave Theory Tech 1996;44:887–895.
28.
Lin JC, Wang YJ: The cap-choke catheter antenna for microwave ablation treatment. IEEE Trans Biomed Eng 1996;43:657–660.
29.
Longo I, Gentili GB, Cerretelli M, Tosoratti N: A coaxial antenna with miniaturized choke for minimally invasive interstitial heating. IEEE Trans Biomed Eng 2003;50:82–88.
30.
Simon CJ, Dupuy DE, Mayo-Smith WW: Microwave ablation: principles and applications. RadioGraphics 2005;25:S69–S83.
31.
Simon CJ, Dupuy DE, Iannitti DA, Lu DSK, Yu NC, Aswad BI, Busuttil RW, Lassman C: Intraoperative triple antenna hepatic microwave ablation. AJR 2007;187:W333–W340.
32.
Hines-Peralta AU, Pirani N, Clegg P, Cronin N, Ryan TP, Liu ZJ, Goldberg SN: Microwave ablation: results with a 2.45-GHz applicator in ex vivo bovine and in vivo porcine liver. Radiology 2006;230:94–102.
33.
Strickland AD, Clegg PJ, Cronin NJ, Swiftt B, Festing M, West KP, Robertson GSM, Lloyd DM: Experimental study of large-volume microwave ablation in the liver. Br J Surg 2002;89:1003–1007.
34.
Shock SA, Meredith K, Warner TF, Sampson LA, Wright AS, Winter TC, Mahvi DM, Fine JP, Lee FT Jr: Microwave ablation with loop antenna: in vivo porcine liver model. Radiology 2004;231:143–149.
35.
Yu NC, Lu DS, Raman SS, Dupuy DE, Simon CJ, Lassman C, Aswad BI, Ianniti D, Busuttil RW: Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters – pilot comparison with pathologic findings. Radiology 2006;239:269–275.
36.
Brace CL, Laeseke PF, Sampson LA, Frey TM, van der Weide DW, Lee FT Jr: Microwave ablation with a single small-gauge triaxial antenna: in vivo porcine liver model. Radiology 2007;242:435–440.
37.
Brace CL, Laeseke PF, Sampson LA, Frey TM, van der Weide DW, Lee FT Jr: Microwave ablation with multiple simultaneously powered small-gauge triaxial antennas: results from an in vivo swine liver model. Radiology 2007;244:151–156.
38.
Sato M, Watanabe Y, Ueda S, Iseki S, Abe Y, Sato N, Kimura S, Okubo K, Onji M: Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 1996;110:1507–1514.
39.
Abe T, Shinzawa H, Wakabayashi H, Aoki M, Sugahara K, Iwaba A, Haga H, Miyano S, Terui Y, Mitsuhashi H, Watanabe H, Matsuo T, Saito K, Saito T, Togashi H, Takahashi T: Value of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in relation to tumor size and location. Endoscopy 2000;32:598–603.
40.
Ido K, Isoda N, Sugano K: Microwave coagulation therapy for liver cancer: laparoscopic microwave coagulation. J Gastroenterol 2001;36:145–152.
41.
Yamashita Y, Sakai T, Maekawa T, Watanabe K, Iwasaki A, Shirakusa T: Thoracoscopic transdiaphragmatic microwave coagulation therapy for a liver tumor. Surg Endosc 1998;12:1254–1258.
42.
Aramaki M, Kawano K, Ohno T, Sasaki A, Tahara K, Kai S, Iwashita Y, Kitano S: Microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology 2004;51:1784–1787.
43.
Hamazoe R, Hirooka Y, Ohtani S, Katoh T, Kaibara N: Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma. Cancer 1995;75:794–800.
44.
Sato M, Watanabe Y, Tokui K, Kawachi K, Sugata S, Ikezoe J: CT-guided treatment of ultrasonically invisible hepatocellular carcinoma. AJR 2000;95:2102–2106.
45.
Kurumi Y, Tani T, Naka S, Shiomi H, Shimizu T, Abe H, Endo Y, Morikawa S: MR-guided microwave ablation for malignancies. Int J Clin Oncol 2007;12:85–93.
46.
Sato M, Watanabe Y, Kashu Y, Nakata T, Hamada Y, Kawachi K: Sequential percutaneous microwave coagulation therapy for liver tumors. Am J Surg 1998;175:322–324.
47.
Murakami R, Yoshimatsu S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K: Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR 1995;164:1159–1164.
48.
Izumi N, Asahina Y, Noguchi O, Uchihara M, Kanazawa N, Itakura J, Himeno Y, Miyake S, Sakai T, Enomoto N: Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001;91:949–956.
49.
Horigome H, Nomura T, Saso K, Itoh M: Standards for selecting microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. AJR 1999;94:1914–1917.
50.
Yamanaka N, Tanaka T, Oriyama T, Furukawa K, Tanaka W, Okamoto E: Microwave coagulonecrotic therapy for hepatocellular carcinoma. World J Surg 1996;20:1076–1081.
51.
Kawamoto C, Ido K, Isoda N, Hozumi M, Nagamine N, Ono K, Sato Y, Kobayashi Y, Nagae G, Sugano K: Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation. Cancer 2005;103:985–993.
52.
Shimada S, Hirota M, Beppu T, Matsuda T, Hayashi N: Complications and management of microwave coagulation therapy for primary and metastatic liver tumors. Surg Today 1998;28:1130–1137.
53.
Mitsuzaki K, Yamashita Y, Nishiharu T, Sumi S, Matsukawa T, Takahashi M, Beppu T, Ogawa M: CT appearance of hepatic tumors after microwave coagulation therapy. AJR 1998;171:1397–1403.
54.
Sato M, Tokui K, Watanabe Y, Lee T, Kohtani T: Generalized intraperitoneal seeding of hepatocellular carcinoma after microwave coagulation therapy: a case report. Hepatogastroenterology 1999;46:2561–2564.
55.
Takamura M, Murakami T, Shibata T, Ishida T, Niinobu T, Kawata S, Shimizu J, Kim T, Monden M, Nakamura H: Microwave coagulation therapy with interruption of hepatic blood in- or outflow: an experimental study. JVIR 2001;12:619–622.
56.
Shibata T, Murakami T, Ogata N: Percutaneous microwave coagulation therapy for patients with primary and metastatic hepatic tumors during interruption of hepatic blood flow. Cancer 2000;88:301–311.
57.
Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, Ikeda K, Inoue K: Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000;89:1245–1251.
58.
Dodd GD, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y, Gillams AR, Karahan OI, Rhim H: Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000;20:9–27.
59.
Dong BW, Zhang J, Liang P, Yu XL, Su L, Yu DJ, Ji XL, Yu G: Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. Int J Hyperthermia 2003;19:119–133.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.